Biotechnology News

February 25, 2013

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals receives U.S. FDA approval for buprenorphine/naloxone tablets, generic Suboxone®, to treat opioid dependence after FDA dismisses brand attempt to block generic competition.

February 25, 2013

BASEL, Switzerland--(BUSINESS WIRE)--Okairos initiates Phase I clinical trial evaluating vaccine against RSV infections

February 25, 2013

ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that the Phase III CENTRICa trial of the investigational integrin inhibitor cilengitide did not meet its primary endpoint of...

February 25, 2013

HYDERABAD, India--(BUSINESS WIRE)--GVK Biosciences Pvt. Ltd. Announces New Distributor in Taiwan

February 24, 2013

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from a Phase III trial, ASTERIA II, which demonstrated that omalizumab met its primary endpoint in patients...

February 23, 2013

SAN ANTONIO, Texas--(BUSINESS WIRE)--Phase III results: tiotropium Respimat® is effective in symptomatic asthma patients irrespective of their allergic status

February 22, 2013

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2012, on Wednesday, March 6, 2013. C. Randal Mills, Ph.D.,...

February 22, 2013

LENEXA, Kan.--(BUSINESS WIRE)--Evogen, Inc. promoted Richard St.Clair to Vice President of Commercialization. St.Clair previously served as Director of Marketing & Business Development. In this new assignment, he will be responsible for...

February 22, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, Inc., the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, today announced that...

February 22, 2013

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its TAP technology, today announced that Roche has reported that the U.S. Food and Drug Administration (FDA) has...

February 22, 2013

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Kadcyla™ (ado-trastuzumab emtansine or T-DM1) for the...

February 22, 2013

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for OR lights and booms

February 22, 2013

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics Inc. (NASDAQ: OXBT) closes on $2.1 million in financing.

February 22, 2013

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that researchers will present new data analyses of the safety and efficacy of the company’s investigational allergy...

February 22, 2013

SAN FRANCISCO--(BUSINESS WIRE)--Shimojani LLC has acquired an exclusive license from Niigata University for worldwide development and commercialization rights to an invention to substantially reduce the risk of hemorrhage in stroke.

February 22, 2013

LONDON--(BUSINESS WIRE)--New report “Competing in the US Clinical Chemistry and Immunodiagnostic Markets” elaborated by Venture Planning Group has been recently published at MarketPublsihers.com

February 22, 2013

CAMBRIDGE, England--(BUSINESS WIRE)--Lab21 has entered into an agreement with IntegraGen to develop a microRNA assay for colorectal cancer designed to further improve patient outcomes.

February 22, 2013

SEATTLE--(BUSINESS WIRE)--Blaze Bioscience Announces Completion of Series A Financing - Brings Total Investment to $9.8 Million.
Tumor PaintTM product candidate BLZ-100 advances to toxicology studies.

February 22, 2013

DAEJEON, South Korea--(BUSINESS WIRE)--Panagene announced it has signed a supply agreement with Dako Denmark A/S to supply PNA oligomer key component for incorporation into Dako’s diagnostic or research products. Dako, an Agilent Technologies...

February 22, 2013

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Medivir AB (STO:MVIR-B) today announced that its partner Janssen now has submitted a regulatory application to the Japanese Ministry of Health & Welfare authorities seeking approval for simeprevir...

February 22, 2013

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) today provides an update to the market post the February 6, 2013 announcement regarding the restructuring of the Tysabri® collaboration with Biogen Idec. As previously announced, under the...

February 21, 2013

VANCOUVER, British Columbia--(BUSINESS WIRE)--BIOTECanada, the national industry association representing 250 biotechnology companies today congratulates CDRD Ventures Inc., (CVI), the commercialization vehicle of The Centre for Drug Research and...

February 21, 2013

NEW YORK--(BUSINESS WIRE)--Lieff Cabraser has filed a personal injury lawsuit against Stryker Orthopaedics charging that the company manufactured and sold a defective artificial hip implant, known as the Rejuvenate System.

February 21, 2013

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. announced today that Christine St.Clare, a former KPMG LLP partner, joined the Company’s Board of Directors effective February 21, 2013.

February 21, 2013

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica and JLL Partners announce that early termination of the waiting period under the Hart-Scott-Rodino Act has been granted, regarding the pending acquisition of BIOC by BC Acquisition Corp.

February 21, 2013

SOUTH SAN FRANCISCO, Calif. & STOCKHOLM--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) and Swedish Orphan Biovitrum (Sobi) (STO: SOBI) today announced that they have entered into a three-year agreement to support the distribution and...

February 21, 2013

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and year ended December 31, 2012. Q4 2012 Highlights and Recent Events The FDA approved COMETRIQ™ (cabozantinib)...

February 21, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, AMAG’s chief executive officer, will participate in the RBC Capital Markets Global Healthcare Conference on Tuesday, February 26,...

February 21, 2013

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced it has completed its previously announced acquisition of Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal...

February 21, 2013

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, reported its results for the fourth...

February 21, 2013

ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI) reported financial results for its fourth quarter ended December 31, 2012 and provided 2013 guidance. Net sales totaled $123.5 million during the fourth quarter ended...

February 21, 2013

NEW YORK--(BUSINESS WIRE)--Medikly today announced the close of a $1.2M Series A round of funding led by Easton Capital Investment Group.

February 21, 2013

DUBLIN--(BUSINESS WIRE)--ICON plc Announces Appointment of Professor William Hall to Board of Directors

February 21, 2013

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kinetigen, Inc. exhibiting at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting

February 21, 2013

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--More than two-thirds of medical science liaison (MSL) team budgets is dedicated to direct salaries and overhead or travel expenses, a recent study from Cutting Edge Information found.

February 21, 2013

ST. PAUL, Minn.--(BUSINESS WIRE)--A program at Regions Hospital to remove patients from a ventilator within six hours after heart surgery improves recovery time and lowers medical costs.

February 21, 2013

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) announced its plenary session program for the 2013 World Congress on Industrial Biotechnology featuring biofuel and biobased product company executives, scientists and...

February 21, 2013

SAN ANTONIO--(BUSINESS WIRE)--Health systems today are under more pressure than ever to improve clinical and business outcomes and increase market share, often through physician group and facility acquisitions. But, integrating and delivering...

February 21, 2013

DENVER--(BUSINESS WIRE)--MPEG LA today announced that the Wisconsin Alumni Research Foundation (WARF) has become a participating patent holder in Librassay®, MPEG LA’s licensing supermarket of diagnostic and research tool patent rights for tests...

February 21, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--SynapDx Corporation’s CEO Stanley Lapidus discusses diagnostic issues at inaugural Autism Investment Conference hosted by Autism Speaks

February 21, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--LabCorp invests $2 million in SynapDx Corporation

February 21, 2013

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for instrument containers

February 21, 2013

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex AB (STO:ALNX): For the fourth quarter October - December · Net sales for the quarter amounted to SEK 27.4 million (27.5). Sales were impacted by a negative currency effect of SEK 1.2 million...

February 21, 2013

SAN ANTONIO--(BUSINESS WIRE)--GenSpera treats first patient in G-202 Phase II hepatocellular cancer trial.

February 21, 2013

ERLANGEN, Germany--(BUSINESS WIRE)--Cerbomed opens up new markets: From March on t-VNS with NEMOS will be available in Italy for the treatment of epilepsies.

February 21, 2013

WALTHAM, Mass.--(BUSINESS WIRE)--N-of-One announced a partnership with Fox Chase Cancer Center to provide molecular interpretation and treatment strategy analysis for genome sequencing and testing provided to advanced cancer patients

February 21, 2013

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, ISIS Pharma and CHDI collaboration advances Huntington’s disease therapy development with state-of-the-art biomarker technology

February 21, 2013

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced top-line results for a Phase 3 study that showed Lyrica® (pregabalin) Capsules CV were as effective as levetiracetam as an adjunctive therapy in adult epilepsy patients...